Tetramethylpyrazine enhances neuroprotection and plasticity in cerebral ischemia-reperfusion injury via RhoA/ROCK2 pathway inhibition
Tetramethylpyrazine (TMP) is an active component of the Chuanxiong, effectively crosses blood-brain barrier (BBB). It exhibits neuroprotective potential in cerebral ischemia-reperfusion injury (CIRI). This study performed middle cerebral artery occlusion/reperfusion (MCAO/R) surgery in rats to evalu...
Saved in:
| Main Authors: | Yixin Zhang, Xin Zhang, Xiaocheng Shi, Weijing Liao, Junbin Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1594283/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tetramethylpyrazine and renal ischemia-reperfusion injury: a systematic review and meta-analysis of preclinical studies
by: Zhongmei Fu, et al.
Published: (2025-06-01) -
Preconditioning with an enriched environment enhances neuroplasticity and functional recovery following cerebral ischemia-reperfusion injury
by: Yi Zhang, et al.
Published: (2025-09-01) -
Neuroprotective effects of phenylacetylglycine via β2AR on cerebral ischemia/reperfusion injury in rats
by: Wenjie Hu, et al.
Published: (2024-12-01) -
Tetramethylpyrazine promotes osteo-angiogenesis during bone fracture repair
by: Jiangbo Ai, et al.
Published: (2025-01-01) -
Cerebral ischemia-reperfusion injury: mechanisms and promising therapies
by: Mingming Yang, et al.
Published: (2025-07-01)